Skip to content

Embecta Corp. EMBC Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
ICU Medical logo
ICU MedicalICUI
AdaptHealth logo
AdaptHealthAHCO

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s amortization expense related to capitalized debt issuance costs?
Embecta Corp. (EMBC) reported amortization expense related to capitalized debt issuance costs of $1.9M in Q1 2026.
How has Embecta Corp.'s amortization expense related to capitalized debt issuance costs changed year-over-year?
Embecta Corp.'s amortization expense related to capitalized debt issuance costs decreased by 5.0% year-over-year, from $2M to $1.9M.
What is the long-term trend for Embecta Corp.'s amortization expense related to capitalized debt issuance costs?
Over 3 years (2022 to 2025), Embecta Corp.'s amortization expense related to capitalized debt issuance costs has grown at a 41.7% compound annual growth rate (CAGR), from $3.2M to $9.1M.